Overview

Tech Summary

Promoter Holding

Posts

FORTIS

201234567897012345678970123456789.6012345678900123456789
-3.05 (-1.09%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 280.65
1D
5D
1M
3M
1Y
5Y
Today's low
275.55
Today's high
283
52 week low
219.75
52 week high
313.45
Volume
765847
About
Tech Summary
DMA(12)
₹235.3
DMA(50)
₹249.58
DMA(100)
₹256.68
DMA(200)
₹265.79
Fund Summary
Market Cap
₹20958.8 Cr.
Enterprise Value
₹21812.98 Cr.
No. of Shares
75.5
P/E
37.75
RoE
-1.62
Debt/Equity
0.21
Valuations
PE Chart
0
PB Chart
2.83.03.23.43.63.8
Promoter Holdings
Public : 22.12%
FII : 29.82%
DII : 16.9%
Promoter : 31.17%
Others : 0%
Charts
Debt/Equity
0.200.250.300.350.400.45
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE vs ROCE
-15-10-505
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
ROE
ROCE
Revenue vs Profitability (1000Cr.)
0.01.02.03.04.05.0
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Revenue
Profit
Margins(%)
-15-10-5051015
Mar, 2018Mar, 2019Mar, 2020Mar, 2021
Net Margin
Gross Margin
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
83% Bullish
17% Bearish
12 live trades of Rs. 1,028,934.05
P
pareshsalvi
 
Reputation: 0 • 
Just now
FORTIS
100 Qty (S) Validity Over₹75
S
somnath-BykQJWALs
 
Reputation: 0 • 
Just now
FORTIS
500 Qty (S) Stoploss Hit-₹300
Posts by FrontPage Users
NewsBot-display-image
Reputation: 29,799  •  Jan 11 12:41 AM
Jhunjhunwala family increases stake in this smallcap
Jhunjhunwala family increases stake in this smallcap
Rekha Jhunjhunwala, as per the latest corporate shareholdings filed, publicly holds 19 stocks with an estimated net worth of over Rs. 11,866.8 crore. Some of the top holdings of the investor include Aptech, Crisil, Indian Hotels and Jubilant Pharmova and Fortis.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Jan 4 3:06 PM
Sensex & Nifty targets, market prediction, top stock picks from 10 brokerages for your 2023 portfolio
Sensex & Nifty targets, market prediction, top stock picks from 10 brokerages for your 2023 portfolio
Top stock picks: The brokerage is bullish on private banks, insurance, select industrials, consumer discretionary, automobiles and telcos. Stocks in its portfolio include Maruti Suzuki, M&M, Sun Pharmaceutical, Fortis Healthcare, Bharti Airtel, HDFC Bank, ICICI Bank, Axis Bank and SBI Life Insurance.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Dec 21, 2022 7:36 PM
Diagnostic players rally up to 6% amid China covid surge
Diagnostic players rally up to 6% amid China covid surge
“The near-term market construct is not favourable for equities. The rising Covid cases in the US, Korea, Brazil, and China is an area of concern. The situation is dire in China. This might impact market sentiments,” V K Vijayakumar, Chief Investment Strategist at Geojit Financial Services said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Dec 16, 2022 3:11 PM
Money-making Ideas! 7 investment themes for stock investors in 2023
Money-making Ideas! 7 investment themes for stock investors in 2023
Hardly any analyst ETMarkets spoke to sees Nifty slipping below the 18,000 mark in the next one year. The most optimistic of bulls are expecting the index to even zoom past the 20,000 mark. Global brokerage BofA Securities has built a base case Nifty target of 19,500 while Morgan Stanley sees the Sensex at 68,500 in 2023.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Dec 14, 2022 12:11 AM
BNP Paribas sees India underperforming EM peers in 2023, excludes ITC, Infosys
BNP Paribas sees India underperforming EM peers in 2023, excludes ITC, Infosys
Valuation of Sensex is the highest among the emerging market peers, all of whom are trading at 0.9-1.7 times their 1-year forward price-to-book value, the brokerage said in a note
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 29, 2022 9:03 PM
Buy Fortis Healthcare; target of Rs 360: Prabhudas Lilladher
Buy Fortis Healthcare; target of Rs 360: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 360 in its research report dated November 14, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 18, 2022 8:21 PM
Sebi spanner:  If I were advising, I would have told IHH to go ahead with the open offer: Sanjay Asher
Sebi spanner: If I were advising, I would have told IHH to go ahead with the open offer: Sanjay Asher
“Once somebody has made an open offer, it has to get allowed to be completed. There is no stay order from Delhi High Court, there is nothing which prevents the open offer to go ahead. Why should the minority shareholders, rather the retail shareholders be allowed to suffer like this? Not allowing the open offer to proceed is completely against the interest of the retail shareholders.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 18, 2022 5:33 AM
Sebi directs IHH to get Delhi High Court nod to go ahead with Fortis open offer
Sebi directs IHH to get Delhi High Court nod to go ahead with Fortis open offer
The IHH-Fortis deal has been stuck due to a legal battle between Japanese firm Daiichi Sankyo and former promoters of Fortis Malvinder Singh and his brother Shivinder
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 18, 2022 12:26 AM
Sebi asks IHH Healthcare to proceed with open offer for Fortis after HC permission
Sebi asks IHH Healthcare to proceed with open offer for Fortis after HC permission
IHH Healthcare Managing Director and CEO Kelvin Loh had stated: "With the recent Supreme Court judgement ruling making clear that we have conducted our investment into Fortis in a fair and transparent manner, we are discussing with Sebi to move ahead with the offer."
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 15, 2022 12:28 PM
Trade Spotlight | What should you do with KIMS Hospitals, Fortis Healthcare, Ambuja Cements on Tuesday?
Trade Spotlight | What should you do with KIMS Hospitals, Fortis Healthcare, Ambuja Cements on Tuesday?
Ambuja Cements is currently trading near its all-time high level which tells that the stock already is in strong momentum.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 14, 2022 10:51 PM
Jhunjhunwala & Co cut stakes in over dozen stocks in Q2
Jhunjhunwala & Co cut stakes in over dozen stocks in Q2
Among the exits, Jhunjhunwala and associates stake dropped below one per cent in Bilcare, Indiabulls Housing Finance and Autoline Industries as of September 30, 2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 14, 2022 10:51 PM
Dr Ashutosh Raghuvanshi on IHH open offer, expansion plans & margin growth
Dr Ashutosh Raghuvanshi on IHH open offer, expansion plans & margin growth
“The second quarter is a seasonally good quarter and there are variations from quarter to quarter and we would typically see that the second quarter is always slightly better. The third quarter is a quarter of the festivals and celebration and during this quarter, the occupancy levels may not go up so dramatically but eventually this is going towards 75% occupancy. Many of our hospitals are even currently working at about 75% occupancy.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 14, 2022 10:46 PM
Dr Ashutosh Raghuvanshi on IHH open offer,expansion plans & margin growth
Dr Ashutosh Raghuvanshi on IHH open offer,expansion plans & margin growth
“The third quarter is a quarter of the festivals and celebration and during this quarter, the occupancy levels may not go up so dramatically but eventually this is going towards 75% occupancy. Many of our hospitals are even currently working at about 75% occupancy.”
The Economic Times
Like
Comment
Share
Add a comment
Swingster Trades-display-image
Reputation: 5,296  •  Nov 14, 2022 5:41 PM

#FORTIS Inverted head and shoulder pattern forming on Weekly basis. Counter looking extremely good from Positional point of view with a reward possibility of 25% and Risk possibility of 11%. Time horizon need be kept next 4-5 months.
Below SL and above Target, Trade setup will be......read more
Chartbusters - chart - 15915139
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 14, 2022 4:46 PM
Fortis Healthcare climbs over 5% after strong 67% rise in Q2 PAT
Fortis Healthcare climbs over 5% after strong 67% rise in Q2 PAT
Its consolidated revenue for the September quarter of FY23 stood at Rs 1,607 crore, up 9.9% as compared to Rs 1,462.5 crore in the corresponding period of the last fiscal. Its Q2FY23 hospital business revenues were at Rs 1,297 crore versus Rs 1,098.5 crore in Q2FY22.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 12, 2022 1:31 PM
IHH Healthcare ready to make open offer for Fortis
IHH Healthcare ready to make open offer for Fortis
It said that following the recent judgment of the Supreme Court, the special leave petition, the original contempt petition and the suo-moto contempt petition are disposed of.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 12, 2022 2:51 AM
Fortis Healthcare Q2 Results: Firm posts Rs 218 crore profit led by strong hospital business, overseas patients
Fortis Healthcare Q2 Results: Firm posts Rs 218 crore profit led by strong hospital business, overseas patients
The company reported a net profit of Rs 131 crore in the corresponding quarter of the previous year. The revenues rose 10% YoY to Rs 1607 crore in Q2FY23 compared to 1463 crore in Q2FY22.​The earnings before interest, tax, depreciation and amortization (EBITDA) stood at Rs 316 crore in Q2FY23, improving by 9% YoY. The EBITDA margin stood at 20%.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 11, 2022 2:01 PM
Corporate Radar: Ajanta Pharma to trade ex-dividend, LIC, M&M results and more
Corporate Radar: Ajanta Pharma to trade ex-dividend, LIC, M&M results and more
Shares of Ajanta Pharma (Rs 7 per share), GMM Pfaudler (Re 1 per share), Siyaram Silk (Rs 4 per share) and Nikko Parks (Re 0.4 per share) will trade ex-dividend. Shares of GPT Infraprojects will trade ex-bonus in respect of the bonus share issue in the ratio of 1:1.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 9, 2022 4:46 PM
After defence, will  railways theme pay dirt next? Hemang Jani answers
After defence, will railways theme pay dirt next? Hemang Jani answers
“Capex as a theme is in vogue and among investors, there is definitely a liking for some of the companies where the overall performance has proved to be good and where the management is guiding for a better growth ahead. From that perspective, Cummins could be one stock to look at.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 9, 2022 4:41 PM
After defence, will  railways theme hit dirt next? Hemang Jani answers
After defence, will railways theme hit dirt next? Hemang Jani answers
“Capex as a theme is in vogue and among investors, there is definitely a liking for some of the companies where the overall performance has proved to be good and where the management is guiding for a better growth ahead. From that perspective, Cummins could be one stock to look at.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Nov 9, 2022 3:06 AM
In talks with Sebi for Fortis open offer: IHH CEO
In talks with Sebi for Fortis open offer: IHH CEO
Kelvin Loh, CEO, IHH Healthcare said IHH got several inbound queries, but the company was not interested in divesting its stake in Fortis as yet.
The Economic Times
Like
Comment
Share
Add a comment
Gyanee-display-image
Reputation: 8,830  •  Nov 3, 2022 2:15 AM
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Oct 27, 2022 9:36 PM
What is the real risk factor for the Reliance stock? Dipan Mehta answers
What is the real risk factor for the Reliance stock? Dipan Mehta answers
“The way Apollo has strategised the capital allocation policy and the value which they are creating in digital business is impressive. I would go with that company. Of course, there are other plays as well but when you like a sector, you go for the market leader and that generally works out pretty well.”
The Economic Times
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Oct 19, 2022 4:46 PM
Is this a good time to accumulate IT stocks? Hemang Jani answers
Is this a good time to accumulate IT stocks? Hemang Jani answers
“For ITC, we are looking at about 19% kind of growth in the EBITDA and their non-cigarette business also will continue to do well – be it FMCG, paperboards and hotel business. In the cigarette business also, we are looking at a steady state kind of growth. We continue to have a positive bias there.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Oct 13, 2022 5:46 PM
IHH Healthcare | Fortis Healthcare: IHH Healthcare taps Sebi door for Fortis open offer
IHH Healthcare | Fortis Healthcare: IHH Healthcare taps Sebi door for Fortis open offer
On 14th December 2018, the Supreme Court had issued an interim order stalling the open offer by IHH. Post September 22 order, various legal experts feel that if a petition gets disposed off, all interim orders get merged with the final order or stand vacated unless mentioned otherwise.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Oct 13, 2022 3:56 PM
IHH Healthcare | Fortis Healthcare: IHH Healthcare taps Sebi door for Fortis open offer
IHH Healthcare | Fortis Healthcare: IHH Healthcare taps Sebi door for Fortis open offer
On 14th December 2018, the Supreme Court had issued an interim order stalling the open offer by IHH. Post September 22 order, various legal experts feel that if a petition gets disposed off, all interim orders get merged with the final order or stand vacated unless mentioned otherwise.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Oct 13, 2022 11:51 AM
IHH Healthcare taps Sebi door on Fortis open offer
IHH Healthcare taps Sebi door on Fortis open offer
On 14th December 2018, the Supreme Court had issued an interim order stalling the open offer by IHH. Post September 22 order, various legal experts feel that if a petition gets disposed off, all interim orders get merged with the final order or stand vacated unless mentioned otherwise.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Oct 13, 2022 11:46 AM
IHH Healthcare taps Sebi door on Fortis open offer
IHH Healthcare taps Sebi door on Fortis open offer
On 14th December 2018, the Supreme Court had issued an interim order stalling the open offer by IHH. Post September 22 order, various legal experts feel that if a petition gets disposed off, all interim orders get merged with the final order or stand vacated unless mentioned otherwise.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 28, 2022 3:56 PM
Auto a buy on dips, 3 stocks to bet on: Hemang Jani
Auto a buy on dips, 3 stocks to bet on: Hemang Jani
“Even if we correct another 3% to 5% at the index level, people would be okay given that we have already gone up quite a lot from June onwards. We should just see to it that in this phase, we are able to navigate without much of a damage and look out for some opportunities where the growth visibility is high.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 28, 2022 1:08 PM
IHH Healthcare in discussions with Indian authorities over stalled open offer in Fortis Healthcare
IHH Healthcare in discussions with Indian authorities over stalled open offer in Fortis Healthcare
The Supreme Court had last week ordered a forensic audit of the share sale of Fortis Healthcare to IHH Healthcare executed in 2018, in a contempt case filed by Japanese firm Daiichi Sankyo Company Ltd against the former promoters of Fortis, Singh brothers -- Malvinder and Shivinder, and others.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 24, 2022 3:21 PM
Can Fin Homes, M&M Fin among 8 BSE500 stocks that lost up to 19% during the week
Can Fin Homes, M&M Fin among 8 BSE500 stocks that lost up to 19% during the week
In the BSE500 index, 345 stocks settled in the red, whereas other 155 stocks posted gains for the week. Only eight stocks were able to rise 10 per cent or more, whereas the same number of stocks clocked double-digit cuts. Benchmark indices - BSE Sensex and Nifty 50 - dropped over a per cent each, while midcap and smallcap indices underperformed as they shed 2 per cent during the week. The BSE500 index was also down by more than a per cent.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 23, 2022 4:06 PM
Add Fortis Healthcare, target price Rs 299:  ICICI Securities
Add Fortis Healthcare, target price Rs 299: ICICI Securities
Fortis Healthcare Ltd., incorporated in the year 1996, is a Mid Cap company (having a market cap of Rs 19466.60 Crore) operating in Hospitals & Allied Services sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 23, 2022 1:41 AM
Ahead of Market: 10 things that will decide D-Staction on Friday
Ahead of Market: 10 things that will decide D-Staction on Friday
Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial Services, said: “Indian markets again showed resilience in the face of global weakness after the US Fed sounded more hawkish in its future action. Nifty opened a gap down but attempted to recover twice during the day, to finally close with a loss of 86 points at 17,630”.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 22, 2022 7:26 PM
Won’t read too much into forensic audit; Fortis Healthcare a buy on dips: Param Desai
Won’t read too much into forensic audit; Fortis Healthcare a buy on dips: Param Desai
“From a business and growth perspective, both the Fortis businesses look pretty solid from a medium-term perspective. There are reasonably good growth drivers and to that extent, I will recommend it to investors to use this dip as more of a buying opportunity from our end.”
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 22, 2022 4:46 PM
Fortis shares tank 16% after SC orders forensic audit for IHH Healthcare share sale
Fortis shares tank 16% after SC orders forensic audit for IHH Healthcare share sale
Shares of Fortis Healthcare plunged 16 per cent to Rs 263 on Thursday. The had stock ended the previous session at Rs 311.20 on BSE.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 22, 2022 2:56 PM
Buy Fortis Healthcare, target price Rs 372:  HDFC Securities
Buy Fortis Healthcare, target price Rs 372: HDFC Securities
Fortis Healthcare Ltd. key Products/Revenue Segments include HealthCare Services, Other Operating Revenue, Lease Rentals, Pharmaceuticals and Export Incentives for the year ending 31-Mar-2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 20, 2022 2:01 PM
Big Movers on D-St: What should investors do with Ambuja Cements, Escorts and Fortis Healthcare?
Big Movers on D-St: What should investors do with Ambuja Cements, Escorts and Fortis Healthcare?
The stock is trading near its breakout point, placed at Rs 580. The key technical indicators are positively poised on long-term as well as medium-term timeframe charts, while its short-term indicators tested the overbought zone and may reverse.
The Economic Times
Like
Comment
Share
Add a comment
Market Direction-display-image
Reputation: 69,478  •  Sep 15, 2022 3:15 PM

FORTIS HLTH
Watch for the levels.
In between zone there can be volatility.
So, manage your positions wisely
Chartbusters - chart - 12520521
1 Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 15, 2022 1:51 PM
Big Movers on D-St: What should investors do with Fortis Healthcare, Allcargo Logistics and Ambuja Cements?
Big Movers on D-St: What should investors do with Fortis Healthcare, Allcargo Logistics and Ambuja Cements?
Stocks that were in focus included names like Fortis Healthcare, which closed with gains of nearly 6 per cent, Allcargo Logistics gained more than 5 per cent, and Ambuja Cements ended with gains of nearly 8 per cent.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 6, 2022 12:21 AM
Yoga, brisk walks & dietary control: How women can combat heart diseases
Yoga, brisk walks & dietary control: How women can combat heart diseases
Regardless of age, a healthy heart is key to overall good health.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 3, 2022 6:46 PM
Nora Fatehi quizzed by Delhi Police for hrs in connection with Sukesh Chandrashekhar's Rs 200 cr money laundering case
Nora Fatehi quizzed by Delhi Police for hrs in connection with Sukesh Chandrashekhar's Rs 200 cr money laundering case
Fatehi was also summoned by the Central agency in October last year.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 3, 2022 6:16 AM
Heart, neuro disorders on the rise in covid survivors
Heart, neuro disorders on the rise in covid survivors
World Health Organization chief scientist Soumya Swaminathan said post-Covid, countries needed to prepare for large increases in cardiovascular, neurological and mental health disorders.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 1, 2022 8:56 PM
Delhi court summons Jacqueline Fernandez on September 26 in Rs 200 cr money laundering case
Delhi court summons Jacqueline Fernandez on September 26 in Rs 200 cr money laundering case
The summons came after the ED's latest charge sheet said the actress enjoyed valuables given by 'conman' Sukesh.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Sep 1, 2022 5:31 AM
Jacqueline Fernandez 'cooked up false story', enjoyed valuables given by 'conman' Sukesh: ED in latest charge sheet
Jacqueline Fernandez 'cooked up false story', enjoyed valuables given by 'conman' Sukesh: ED in latest charge sheet
Additional Sessions Judge Praveen Singh on Wedneday took cognizance of the second supplementary charge sheet filed by the Enforcement Directorate(ED) in the Rs 200 crore money laundering case, and asked Fernandez to appear before the court on September 26.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Aug 30, 2022 1:36 AM
Ahead of Market: 10 things that will decide D-St action on Tuesday
Ahead of Market: 10 things that will decide D-St action on Tuesday
Rupak De, Senior Technical Analyst at LKP Securities, said the momentum oscillator RSI is in a bearish crossover and falling towards the oversold zone. “The short-term trend, at the juncture, looks weak on the lower end, and the index may drift down towards 17,000-16,950 over the short term. On the higher end, resistance is visible at 17,500,” he said.
The Economic Times
Like
Comment
Share
Add a comment
Hangout traders-display-image
Reputation: 8,423  •  Aug 28, 2022 2:37 PM

#FORTIS - 15 minute timeframe
after a breakout on daily timeframe , stock is consoldating we can capture this move and make some intraday profits
Chartbusters - chart - 11945310
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Aug 26, 2022 5:41 AM
Pricing authority caps rates of key diabetes drugs
Pricing authority caps rates of key diabetes drugs
India's drug pricing authority has brought two key anti-diabetic drugs - Sitagliptin-Metformin combination and Linagliptin-Metformin combination - under price control. For a 2.5 mg Linagliptin-metformin tablet, the price has been fixed at 16.17, and for the same combination in 5 mg strength, the price will be 25.33 per tablet.
The Economic Times
Like
Comment
Share
Add a comment
V Trade Point-display-image
Reputation: 1,638  •  Aug 22, 2022 2:43 PM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 29,799  •  Aug 22, 2022 5:51 AM
India, UAE join hands to launch projects in Africa
India, UAE join hands to launch projects in Africa
Last week, a joint India-UAE healthcare delegation visited Tanzania, recipient of India's biggest line of credit in Africa, to explore investment opportunities and meet senior government officials. The objective of the visit was to identify specific projects for collaboration with government and private healthcare providers in Tanzania.
The Economic Times
Like
Comment
Share
Add a comment
Load More Posts